Amanote Research
Register
Sign In
Prm42 - Cost Model of Switching From Enbrel to Etanercept Biosimilars, for Non Medical Reasons, in Rheumatoid Arthritis Patients in Spain
Value in Health
- United Kingdom
doi 10.1016/j.jval.2018.09.2165
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
October 1, 2018
Authors
C Peral
M Valderrama
M Montoro
S Gomez
M Tarallo
Publisher
Elsevier BV